Technical Analysis for TARS - Tarsus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 22.98 -1.03% -0.24
TARS closed down 1.03 percent on Friday, October 23, 2020, on 44 percent of normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical TARS trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Doji - Bearish? Reversal 0.00%
New 52 Week High Strength 0.00%
Inside Day Range Contraction -1.03%
New 52 Week Closing High Bullish -6.20%
New 52 Week High Strength -6.20%
Inside Day Range Contraction 8.35%
Older End-of-Day Gignals for TARS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
New 52 Week High 3 days ago
Up 10% 3 days ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. Tarsus Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Irvine, California.
Biopharmaceutical Organ Systems Anatomy Rosacea Blepharitis Meibomian Gland

Is TARS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.55
52 Week Low 15.32
Average Volume 126,333
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Fundamentals Value
Market Cap 442.57 Million
Num Shares 19.3 Million
EPS
Price-to-Sales 0.00
Price-to-Book 8.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.01
Resistance 3 (R3) 29.53 28.04 28.01
Resistance 2 (R2) 28.04 26.50 27.78 27.67
Resistance 1 (R1) 25.51 25.56 24.77 24.99 27.33
Pivot Point 24.02 24.02 23.65 23.76 24.02
Support 1 (S1) 21.49 22.48 20.75 20.97 18.63
Support 2 (S2) 20.00 21.54 19.74 18.29
Support 3 (S3) 17.47 20.00 17.96
Support 4 (S4) 16.95